09:59 AM EDT, 05/13/2024 (MT Newswires) -- Recursion Pharmaceuticals ( RXRX ) said Monday that BioHive-2, the company's new NVIDIA (NVDA)-powered artificial intelligence supercomputer, has been completed.

Recursion's Chief Technology Officer Ben Mabey said the company expects BioHive-2 to support its "computational horsepower" and expedite the use of its dataset.

The company's shares were up more than 14% in recent Monday trading.

Price: 9.87, Change: +1.27, Percent Change: +14.77